Literature DB >> 1730479

Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1.

J T Bossé1, R P Johnson, M Nemec, S Rosendal.   

Abstract

The isotype-specific antibody responses in serum and in nasal and pulmonary lavage fluids of swine following aerosol immunization with an attenuated strain of Actinobacillus pleuropneumoniae serotype 1, strain CM5A, was investigated. The presence of immunoglobulin G (IgG), IgA, and IgM with specificities for capsular polysaccharide, lipopolysaccharide, and hemolysin was determined by enzyme-linked immunosorbent assay by using purified antigens. Strain CM5A induced serum antibodies of each isotype to the three antigens. The serum antibody response was sustained and typical of persistent antigenic stimulation. The specific IgM response decreased and the specific IgG response increased after challenge with strain CM5. IgA specific for the three antigens was detected in nasal secretions from all immune pigs, whereas specific IgG could only be detected in samples contaminated with blood. Both IgA and IgG specific for each of the antigens were detected in pulmonary lavage samples. There was no significant increase in specific IgA in nasal secretions; however, levels of lipopolysaccharide-specific and hemolysin-specific IgG and IgA in pulmonary secretions rose after aerosol challenge with strain CM5. Passive transfer of immune swine serum resulted in protection against pleuropneumonia and in levels of specific serum IgG which were similar to those in actively immunized pigs. It is concluded that specific serum IgG antibodies are important in protection from porcine pleuropneumonia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730479      PMCID: PMC257652          DOI: 10.1128/iai.60.2.479-484.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Identification of the heat-labile hemolysin of Actinobacillus pleuropneumoniae serotype 1.

Authors:  J Devenish; S Rosendal
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

2.  Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana; B Mathison
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

3.  Influence of immunization procedures on upper respiratory tract immunity in cattle.

Authors:  J R Duncan; R G Thomson
Journal:  Can J Comp Med       Date:  1970-01

4.  Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection.

Authors:  V J Rapp; R F Ross
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors:  B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae.

Authors:  S Rosendal; J Devenish; J I MacInnes; J H Lumsden; S Watson; H Xun
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

7.  Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs.

Authors:  B W Fenwick; B I Osburn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  Protective efficacy of capsule extracts of Haemophilus pleuropneumoniae in pigs and mice.

Authors:  S Rosendal; O P Miniats; P Sinclair
Journal:  Vet Microbiol       Date:  1986-09       Impact factor: 3.293

9.  Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.

Authors:  R P Darveau; R E Hancock
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

10.  Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5.

Authors:  T J Inzana; J Ma; T Workman; R P Gogolewski; P Anderson
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more
  14 in total

1.  Urease activity may contribute to the ability of Actinobacillus pleuropneumoniae to establish infection.

Authors:  J T Bossé; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Influence of Serum and Glucose Additives on Survival of Actinobacillus pleuropneumoniae Aerosolized from the Freeze-Dried State.

Authors:  A Hensel
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

3.  Comparative pathogenicity of different Actinobacillus suis O/K serotypes.

Authors:  D Slavić; J DeLay; M A Hayes; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

4.  Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol.

Authors:  R Pabst; S Delventhal; A Gebert; A Hensel; K Petzoldt
Journal:  Lung       Date:  1995       Impact factor: 2.584

5.  Field experience with two different vaccination strategies aiming to control infections with Actinobacillus pleuropneumoniae in a fattening pig herd.

Authors:  Marie Sjölund; Per Wallgren
Journal:  Acta Vet Scand       Date:  2010-03-25       Impact factor: 1.695

6.  Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.

Authors:  Meili Shao; Yong Wang; Chunlai Wang; Yang Guo; Yonggang Peng; Jiandong Liu; Guangxing Li; Huifang Liu; Siguo Liu
Journal:  Acta Vet Scand       Date:  2010-09-11       Impact factor: 1.695

7.  Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.

Authors:  T J Inzana; J Todd; H P Veit
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Phagocytosis and killing of Actinobacillus pleuropneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs.

Authors:  T L Cruijsen; L A Van Leengoed; T C Dekker-Nooren; E J Schoevers; J H Verheijden
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Flagella and Motility in Actinobacillus pleuropneumoniae.

Authors:  Erasmo Negrete-Abascal; Magda E Reyes; Rosa M García; Sergio Vaca; Jorge A Girón; Octavio García; Edgar Zenteno; Mireya De La Garza
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

10.  Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.

Authors:  A Hensel; R Pabst; S Bunka; K Petzoldt
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.